Effect of Eriocitrin Supplementation in Subjects With Intermediate Hyperglycemia

计划入组 120 人 · 首次发布于 2017 年 7 月 12 日

Chronic Dorzagliatin on Insulin and Incretin Function in Intermediate Hyperglycemia and Type 2 Diabetes

计划入组 30 人 · 首次发布于 2024 年 11 月 4 日

Engagement of coMmunity Through Participatory Learning and Action for cOntrol and preVEntion of Type II Diabetes and Its Risk Factors [EMPOWER-D]

计划入组 12,744 人 · 首次发布于 2024 年 8 月 19 日

Malate Like Intermediate

C₄H₄O₅

TETRAHEDRAL INTERMEDIATE OF BLASTICIDIN S

C₁₇H₂₈N₈O₆

intermediate-acting recombinant human insulin

Hua Medicine's Dorzagliatin Shows Promise in Restoring β-Cell Glucose Sensitivity in Asian Populations

Real-World Study Reveals Lower Hyperglycemia Management Burden with Capivasertib Versus Alpelisib in Metastatic Breast Cancer

MRPL Secures US Patent for Pharmaceutical Intermediate Production Technology